All news


New member : Novasep, leading international provider of services for the Life Sciences industry


Novasep is an international group with annual revenues of €250 m, and leader in the life sciences industry for the production and purification of molecules at industrial scale. The company has recently invested €10 m in a fully integrated Antibody Drug Conjugate (ADC) facility.


The dynamism of Clinical Research of Nantes University Hospital and the ICO is recognized by INCa

After running more than 300 early trials and treating 1 200 patients and since obtaining CLIP2 certification, the dynamism of Clinical Research of Nantes University Hospital and the ICO (West Cancer Institute) has been recognized by the National Cancer Institute (INCa). This certification which is given to the best French centers who have the capacity to conduct early stage clinical trials in cancer, will help to facilitate the access of French patients to innovative molecules and showcase French research with the aim of making it more attractive and of facilitating exchanges with international laboratories.


€5.8 million to start a new era in vaccine purification

Logo Affilogic

The DiViNe initiative, a joint European collaboration of renowned experts, convinced the European Commission. Its main concept is “positive“ vaccines purification by affinity chromatography based on 2 innovative nanotechnologies for higher yield and lower footprint. The six participating partners, among which Affilogic, member of Atlanpole Biotherapies, will receive more than €5.8 million in financial support from the new EU’s Horizon 2020 Framework Program.


TRONICO certified ISO 13485 !


TRONICO is certified ISO 13485 for the scope "industrialisation, circuit board manufacturing, mechanical and eletronic integration and repair of electronic subassemblies for medical devices", since 27th July 2015. The audit was carried out by Bureau Veritas in June, in the facilities of St Philbert de Bouaine (85), and did not show any noncompliance. This certification guarantees an optimum quality level for the manufacture of electronic systems dedicated to medical sector. Tronico is an administrator member of Atlanpole Biotherapies, vice-President for "innovative technologies for biotherapies".


Valneva and PaxVax Enter into Marketing and Distribution Agreement


Valneva and PaxVax, Inc., a fully integrated specialty vaccine company focused on travel, announced today that they have entered into a marketing and distribution agreement for their respective travel vaccines, DUKORAL® and Vivotif®.